Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India

Sci Rep. 2020 Apr 29;10(1):7214. doi: 10.1038/s41598-020-64309-5.

Abstract

Although the prevalences of HIV and HCV are significantly higher amongst PWID in India compared to the general population, the strains circulating within this group have not been well-characterized. Through subgenomic sequencing of viruses present in residual plasma from an HIV/HCV prevalence study conducted amongst PWID across five cities in India in 2016-2017, a total of N = 498 HCV and N = 755 HIV strains were classified from N = 975 study participants. Considerable HCV diversity was identified, with different strains predominating in each region of the country. Overall, the most common strain was genotype 3a (39.0%), with genotypes 1a (26.9%), 1b (3.0%), 1c (0.2%), 3b (20.7%), 3i (2.0%), 4a (0.2%), 4d (1.0%), 6 (1.8%), 6n (4.8%), 6 v (0.2%) and one unclassifiable recombinant specimen (0.2%) also identified. The majority of the HIV specimens were subtype C (96.7%), although subtype A (0.4%), CRF01_AE (0.4%) and unique recombinant forms (URFs, 2.5%) were also detected. Notably, the geographical restriction of HIV subtype A and CRF01_AE, and HCV genotypes 4 and 6 to specific sites suggests distinct novel introductions of HIV and HCV into PWID populations, potentially via drug trafficking routes from neighboring countries where these strains are common.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Genotype*
  • HIV Infections* / epidemiology
  • HIV Infections* / genetics
  • HIV-1 / genetics*
  • Hepacivirus / genetics*
  • Hepatitis C* / epidemiology
  • Hepatitis C* / genetics
  • Humans
  • India / epidemiology
  • Male
  • Phylogeny*
  • Prevalence
  • Substance Abuse, Intravenous* / epidemiology
  • Substance Abuse, Intravenous* / genetics
  • Substance Abuse, Intravenous* / virology